NEW YORK, April 25, 2019 /PRNewswire/ -- Precision for Value, part of Precision Value & Health, the market leader in supporting global pharmaceutical and life science companies in demonstrating the value and outcomes of innovative medical products, today announced further strategic expansion of its Access Experience Team with the hiring of former payer and integrated delivery network (IDN) decision makers Ryan Cox, Dan Danielson, and Erin Lopata.
In addressing their client's urgent need to leverage real-world market insights in response to growing public, government, and payer scrutiny over drug pricing and access, Precision has assembled the Access Experience Team, an industry-leading core of 22 former market access decision makers with a direct understanding of the evolving drug marketplace and strong ties to the payer community. By understanding how market access stakeholders measure value and the supporting evidence, the Access Experience Team has worked across Precision's business units to help dozens of clients secure desired levels of market access for their innovative medical treatments.
"As the healthcare marketplace continues to evolve and change, new strategies and stakeholders are gaining in prominence—including IDNs, pharmacoeconomics, value analysis, quality measures, and integration between payers and PBMs," explains Jeremy Schafer, senior vice president and head of the Access Experience Team. "To meet these new challenges, Precision is excited to be leveraging the veteran expertise of Ryan, Dan, and Erin; their strategies in navigating these emerging areas will allow us to keep pace and further augment our market-leading Access Experience Team of former access decision makers, providing even more value to our global clients."
Ryan Cox, BS Pharma, RPh, MBA, brings over 25 years of pharmacy experience, including nearly 20 years of experience in managed care; he joins the Access Experience Team in the role of vice president.
Prior to coming to Precision, Ryan was Director of Specialty Pharmacy Strategies at Highmark Blue Cross Blue Shield, where he was responsible for overall specialty drug strategy. He led initiatives that focused on optimizing utilization and reimbursement for high-cost specialty medications, including site of care. He also worked closely with pharmaceutical manufacturers on establishing benchmarks for risk-based contracts.
Previous to Highmark, Ryan held senior positions at Humana, CareSource (Dayton, Ohio), and Anthem (WellPoint).
Dan Danielson, RPh, MS, brings over 15 years of expertise developing and leading pharmacy programs in the health plan and PBM industry to the Access Experience Team; he joins as senior director.
Prior to joining Precision, he led the Premera Blue Cross Drug Management Program, where he was responsible for forecasting the impact of high-cost pharmaceuticals and developing utilization management programs to assure clinically appropriate and cost-effective access. As a recognized expert in value and technology assessment, Dan led the deployment of Premera's Value-Based Formulary and managed its independent Value Assessment Committee. Dan's areas of expertise include Value and Technology Assessment, UM, formulary development, value frameworks, budget impact models, cost-effectiveness/comparative effectiveness, and P&T.
Erin Lopata, RPh, MPH, brings over a decade of experience to Precision, joining in the role of senior director, Access Experience Team.
Prior to joining Precision, Erin served in the role of Manager, Clinical Pharmacy for UPMC Health Plan, where she was responsible for developing and implementing a strategic plan for clinical pharmacy services, coordination of contracting services, compliance, and formulary management and maintenance. Erin played a bridging role between the IDN and health plan of UPMC to align formulary and market access strategies between the two entities. Erin also was part of the Specialty Pharmacy and Clinical Pharmacy Specialist teams for UPMC.
About Precision for Value's Access Experience Team
Precision for Value's Access Experience Team is an internal consulting group of former payers who use their real-life experiences to develop more relevant ways to demonstrate and communicate value, working across Precision's business units to assist clients in making critical market access decisions. The Access Experience Team consists of individuals who previously held decision maker roles at leading health plans, PBMs, IDNs, employer coalitions, and specialty pharmacies.
About Precision for Value
Precision for Value supports commercial excellence for global pharmaceutical and life science clients through the demonstration and communication of product value and outcomes. The Precision for Value teams provide clients with services grounded in decades of industry knowledge, demonstrated analytics proficiency, and marketing and communications prowess—making Precision for Value the preferred strategic partner in the industry. Precision for Value is part of Precision Value & Health, the leading partner to pharmaceutical and life science companies in improving health outcomes by establishing the value of medical innovations and expanding global market access for patients. For more information, please visit www.precisionforvalue.com.
Louis Landon, Precision Medicine Group Media Relations
SOURCE Precision for Value